Ongoing investigations into this medication are demonstrating significant findings regarding body composition . Initially intended for treating type 2 diabetes , this GLP-1 receptor agonist has proven https://opensocialfactory.com/story26005375/semaglutide-research-unlocking-new-weight-loss-potential